- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Palisade Bio (PALI)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 5.25 mm | 5.25 mm | 5.25 mm | 5.25 mm | 5.25 mm | 5.25 mm |
| Cash burn (monthly) | 63.33 k | 234.42 k | 974.00 k | 954.75 k | 1.18 mm | 840.33 k |
| Cash used (since last report) | 231.51 k | 856.91 k | 3.56 mm | 3.49 mm | 4.33 mm | 3.07 mm |
| Cash remaining | 5.02 mm | 4.40 mm | 1.69 mm | 1.76 mm | 923.67 k | 2.18 mm |
| Runway (months of cash) | 79.3 | 18.8 | 1.7 | 1.8 | 0.8 | 2.6 |
| 13F holders | Current |
|---|---|
| Total holders | 9 |
| Opened positions | 5 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 220.80 mm |
| Total shares | 3.77 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Regional Medical Center Yuma | 2.25 mm | $5.55 mm |
| Lind Global Fund II | 743.31 k | $543.00 k |
| L1 Capital Global Opportunities Master Fund | 584.96 k | $456.00 k |
| Intracoastal Capital | 131.09 k | $0.00 |
| Armistice Capital | 52.00 k | $184.60 mm |
| JPM JPMorgan Chase & Co. | 8.20 k | $29.11 mm |
| Federation des caisses Desjardins du Quebec | 100.00 | $355.00 k |
| UBS UBS | 31.00 | $110.00 k |
| WFC Wells Fargo & Company | 21.00 | $75.00 k |
| Proequities | 0.00 | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Jan 26 | Williams Donald Allen | Common Stock | Buy | Acquire P | No | No | 1.88 | 5,000 | 9.40 k | 5,728 |
| 6 Oct 25 | Emil Chuang | RSU Common Stock | Grant | Acquire A | No | No | 0 | 510,700 | 0.00 | 510,700 |
| 6 Oct 25 | John David Finley | RSU Common Stock | Grant | Acquire A | No | No | 0 | 9,179,400 | 0.00 | 9,179,400 |
| 6 Oct 25 | Mitchell Lawrence Jones | RSU Common Stock | Grant | Acquire A | No | No | 0 | 7,665,800 | 0.00 | 7,665,800 |
| 6 Oct 25 | Wei Binxian | RSU Common Stock | Grant | Acquire A | No | No | 0 | 510,700 | 0.00 | 510,700 |